PEDİATRİK VE ADOLESAN BRONŞEKTAZİLİ HASTALARDA PULMONER REHABİLİTASYON

Yıl 2022, Cilt: 4 Sayı: 3, 174 - 183, 21.10.2022

Fatma Dilara Akar , Esra Pehlivan

https://doi.org/10.57224/jhpr.1063115

Öz

Bronşektazi, kronik inflamasyon ve enfeksiyonun bronş duvarlarında oluşturduğu hasara bağlı olarak bir veya birden fazla bronşta meydana gelen dilatasyon ve harabiyet ile karakterize kronik bir akciğer hastalığıdır. Hastalığın yönetiminde pulmoner rehabilitasyon önemli bir yer tutmaktadır. Hastalık yönetimine ilişkin çalışmaların çoğu yetişkin grubu kapsamaktadır. Bu doğrultuda çalışmanın amacı, pediatrik ve adolesan bronşektazili hastalarda pulmoner rehabilitasyonun etkinliğini araştırmaktır.
PubMed, Cochrane Library, PEDro ve TRDizin veri tabanları Aralık 2021’e kadar arandı. Pediatrik, adolesan bronşektazi hastalarında pulmoner rehabilitasyon, hava yolu temizleme teknikleri ve egzersiz içerikli tedaviler uygulanan ya da rehabilitasyona katkı sağlayacağı düşünülen çalışmalar dahil edildi.
Toplamda 161 makale bulundu. Tam metinler okunduktan sonra belirlenen dahil edilme kriterlerini karşılayan 7 çalışma seçildi.
Pediatrik ve adolesan bronşektazili hastalarda pulmoner rehabilitasyonun etkisiyle hastalık semptomları azaltılıp yaşam kalitesi arttırılabilir. Gelecekteki çalışmalarla pediatrik ve adolesan bronşektazili gruba yönelik fiziksel aktivite ve egzersiz önerileri fikir birliğinden ziyade kanıta dayalı olarak verilebilir.

Anahtar Kelimeler

Bronşektazi, Pediatrik, Adolesan, Pulmoner Rehabilitasyon

Kaynakça

• 1. Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bronchiectasis. Nature Reviews Disease Primers. 2018;4(1).
• 2. Imam JS, Duarte AG. Non-CF bronchiectasis: Orphan disease no longer. Vol. 166, Respiratory Medicine. W.B. Saunders Ltd; 2020.
• 3. Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 2000;162(4 I):1277–84.
• 4. Mysliwiec V, Pina JS. Bronchiectasis: The “other” obstructive lung disease. Postgraduate Medicine. 1999;106(1):123–31.
• 5. Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest [Internet]. 1995;108(4):955–61. Available from: http://dx.doi.org/10.1378/chest.108.4.955
• 6. Dimakou K, Triantafillidou C, Toumbis M, Tsikritsaki K, Malagari K, Bakakos P. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Respiratory Medicine. 2016;116:1–7.
• 7. King PT, Holdsworth SR, Farmer M, Freezer N, Villanueva E, Holmes PW. Phenotypes of adult bronchiectasis: Onset of productive cough in childhood and adulthood. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2009;6(2):130–6.
• 8. King P, Holdsworth S, Freezer N, Holmes P. Bronchiectasis. Internal Medicine Journal. 2006;36(11):729–37.
• 9. O’Donnell AE. Bronchiectasis update. Vol. 31, Current Opinion in Infectious Diseases. Lippincott Williams and Wilkins; 2018. p. 194-8.
• 10. Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. European Respiratory Journal [Internet]. 2017;50(3). Available from: http://dx.doi.org/10.1183/13993003.00629-2017
• 11. Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. European Respiratory Journal [Internet]. 2015;45(5):1446–62. Available from: http://dx.doi.org/10.1183/09031936.00119114
• 12. Chang AB, Grimwood K, Boyd J, Fortescue R, Powell Z, Kantar A. Management of children and adolescents with bronchiectasis: Summary of the ers clinical practice guideline. Vol. 17, Breathe. European Respiratory Society; 2021.
• 13. McCallum GB, Binks MJ. The epidemiology of chronic suppurative lung disease and bronchiectasis in children and adolescents. Vol. 5, Frontiers in Pediatrics. Frontiers Media S.A.; 2017.
• 14. O’Grady KAF, Grimwood K. The likelihood of preventing respiratory exacerbations in children and adolescents with either chronic suppurative lung disease or bronchiectasis. Vol. 5, Frontiers in Pediatrics. Frontiers Media S.A.; 2017.
• 15. Lee AL, Button BM, Tannenbaum EL. Airway-clearance techniques in children and adolescents with chronic suppurative lung disease and bronchiectasis. Vol. 5, Frontiers in Pediatrics. Frontiers Media S.A.; 2017.
• 16. Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Vol. 392, The Lancet. Lancet Publishing Group; 2018. p. 866–79.
• 17. Maglione M, Aksamit T, Santamaria F. Paediatric and adult bronchiectasis: Specific management with coexisting asthma, COPD, rheumatological disease and inflammatory bowel disease. Vol. 24, Respirology. Blackwell Publishing; 2019. p. 1063–72.
• 18. Ilowite J, Spiegler P, Chawla S. Bronchiectasis: New findings in the pathogenesis and treatment of this disease. Current Opinion in Infectious Diseases. 2008;21(2):163–7.
• 19. Moulton BC, Barker AF. Pathogenesis of Bronchiectasis. Clinics in Chest Medicine [Internet]. 2012;33(2):211–7. Available from: http://dx.doi.org/10.1016/j.ccm.2012.02.004
• 20. Ozalp O, Inal-Ince D, Calik E, Vardar-Yagli N, Saglam M, Savci S, et al. Extrapulmonary features of bronchiectasis: Muscle function, exercise capacity, fatigue, and health status. Multidisciplinary Respiratory Medicine. 2012;7(1):3–8.
• 21. Pasteur MC, Bilton D, Hill AT. British thoracic society guideline for non-CF bronchiectasis. Thorax. 2010;65(SUPPL. 1).
• 22. Chang AB, Bell SC, Torzillo PJ, King PT, Maguire GP, Byrnes CA, et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Medical Journal of Australia. 2015;202(1):21–4.
• 23. Lee AL, Gordon CS, Osadnik CR. Exercise training for bronchiectasis. Cochrane Database of Systematic Reviews. 2018;(8).
• 24. Hill AT, Sullivan AL, Chalmers JD, de Soyza A, Stuart Elborn J, Andres Floto R, et al. British thoracic society guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1).
• 25. Camargo AA de, Boldorini JC, Holland AE, Silva RA, Castro D, Lanza FDC, et al. Original Research Original Research Original Research. 2018;98(3):153–61.
• 26. Alison JA, McKeough ZJ, Johnston K, McNamara RJ, Spencer LM, Jenkins SC, et al. Australian and New Zealand Pulmonary Rehabilitation Guidelines. Respirology. 2017;22(4):800–19.
• 27. Anuradha KWDA, Gunathilaka PKG, Wickramasinghe VP. Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: A randomized control trial. Pediatric Pulmonology. 2021 Feb 1;56(2):509–15.
• 28. Gokdemir Y, Hamzah A, Erdem E, Cimsit C, Ersu R, Karakoc F, et al. Quality of life in children with non-cystic-fibrosis bronchiectasis. Respiration. 2014;88(1):46–51.
• 29. Respiratory E, Annual S. European Respiratory Society Annual Congress 2010. Analysis. 2010;3:10–1.
• 30. Dik J, Saglam M, Tekerlek H, Vardar-Yagli N, Calik-Kutukcu E, Inal-Ince D, et al. Visuomotor reaction time and dynamic balance in children with cystic fibrosis and non-cystic fibrosis bronchiectasis: A case-control study. Pediatric Pulmonology. 2020;55(9):2341–7.
• 31. Zeren M, Gurses HN, Denizoglu Kulli H, Ucgun H, Cakir E. Sit-to-stand test in children with bronchiectasis: Does it measure functional exercise capacity? Heart and Lung. 2020 Nov 1;49(6):796–802.
• 32. Emiralioglu N, Dogru D, Yalcin S, Tugcu GD, Yalcin E, Ozcelik U, et al. Impact of Surgery on Growth, Pulmonary Functions, and Acute Pulmonary Exacerbations in Children with Non-Cystic Fibrosis Bronchiectasis. Thoracic and Cardiovascular Surgeon. 2019;67(1):58–66.
• 33. O’Rourke C, Schilling S, Martin R, Joyce P, Bernadette Chang A, Kapur N. Is out-patient based treatment of bronchiectasis exacerbations in children comparable to inpatient based treatment? Pediatric Pulmonology. 2020 Apr 1;55(4):994–9.
• 34. Chang AB, Fortescue R, Grimwood K, Alexopoulou E, Bell L, Boyd J, et al. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. European Respiratory Journal [Internet]. 2021;58(2):1–29. Available from: http://dx.doi.org/10.1183/13993003.02990-2020
• 35. Dixon E, Puckey M, Collins N, Marsh G, Pabary R. Striving for perfection, accepting the reality: A reflection on adherence to airway clearance and inhalation therapy for paediatric patients with chronic suppurative lung disease. Paediatric Respiratory Reviews [Internet]. 2020;34(xxxx):46–52. Available from: https://doi.org/10.1016/j.prrv.2019.04.002
• 36. Lee AL, Hill CJ, Cecins N, Jenkins S, McDonald CF, Burge AT, et al. The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis - a randomised controlled trial. Respiratory Research [Internet]. 2014;15(1):1–10. Available from: Respiratory Research
• 37. Burtin C, Hebestreit H. Rehabilitation in patients with chronic respiratory disease other than chronic obstructive pulmonary disease: Exercise and physical activity interventions in cystic fibrosis and non-cystic fibrosis bronchiectasis. Respiration. 2015;89(3):181–9.
• 38. Kelly C, Grundy S, Lynes D, Evans DJW, Gudur S, Milan SJ, et al. Self-management for bronchiectasis. Cochrane Database of Systematic Reviews. 2018;2018(2).